Bio-Rad Laboratories (BIO) Change in Acquisitions & Divestments (2010 - 2026)

Bio-Rad Laboratories (BIO) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $145.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 644.1% year-over-year to $145.1 million; the TTM figure through Mar 2026 stood at $187.6 million (up 266.46% YoY), while the FY2025 annual figure was $62.0 million, down 68.89% from the prior year.
• Change in Acquisitions & Divestments climbed to $145.1 million in Q1 2026 per BIO's latest filing, from $3.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $774.1 million in Q3 2024 and bottomed at -$701.2 million in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $95.1 million across 5 years, with a median of $107.7 million in 2022.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments surged 4596.82% — and 2024, when it plunged 530.54%.
• Bio-Rad Laboratories' Change in Acquisitions & Divestments stood at $165.6 million in 2022, then retreated by 1.63% to $162.9 million in 2023, then slumped by 530.54% to -$701.2 million in 2024, then jumped by 100.43% to $3.0 million in 2025, then soared by 4736.67% to $145.1 million in 2026.
• Business Quant data shows BIO's Change in Acquisitions & Divestments at $145.1 million in Q1 2026, $3.0 million in Q4 2025, and -$386.6 million in Q3 2025.